Bolt Biotherapeutics Stock In The News
| BOLT Stock | USD 0.41 0 0.98% |
Our overall analysis of Bolt Biotherapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Bolt Biotherapeutics. The specific impact of Bolt Biotherapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bolt Biotherapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bolt Biotherapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bolt Biotherapeutics Backtesting and Bolt Biotherapeutics Hype Analysis. For more information on how to buy Bolt Stock please use our How to Invest in Bolt Biotherapeutics guide.
Bolt |
Bolt Biotherapeutics Today Top News and Investor Outlook
Bolt Biotherapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bolt and other traded companies coverage with news coverage. We help investors stay connected with Bolt headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Bolt Stock performance. Please note that trading solely based on the Bolt Biotherapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bolt Biotherapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bolt earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bolt Biotherapeutics that are available to investors today. That information is available publicly through Bolt media outlets and privately through word of mouth or via Bolt internal channels. However, regardless of the origin, that massive amount of Bolt data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bolt Biotherapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bolt Biotherapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bolt Biotherapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bolt Biotherapeutics alpha.
Bolt Largest EPS Surprises
Earnings surprises can significantly impact Bolt Biotherapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-03-31 | -0.51 | -0.45 | 0.06 | 11 | ||
2023-11-09 | 2023-09-30 | -0.5 | -0.43 | 0.07 | 14 | ||
2023-03-29 | 2022-12-31 | -0.6 | -0.53 | 0.07 | 11 | ||
2022-08-10 | 2022-06-30 | -0.68 | -0.61 | 0.07 | 10 | ||
2022-05-12 | 2022-03-31 | -0.72 | -0.64 | 0.08 | 11 | ||
2022-03-30 | 2021-12-31 | -0.82 | -0.73 | 0.09 | 10 |
Bolt Biotherapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bolt Biotherapeutics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
13th of March 2025
Ryan Breslow Settles Lawsuits After Returning As Bolt CEO I Made A Ton Of Mistakes at forbes.com
7th of March 2025
Disposition of 1134 shares by Engleman Edgar of Bolt Biotherapeutics at 0.93 subject to Ru... at MacroaxisInsider
26th of February 2025
Bolt Technology Reportedly Exploring IPO for Ride-Hailing Operation at pymnts.com
11th of February 2025
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development w... at gurufocus.com
28th of January 2025
BOLT Stock Earnings Bolt Biotherapeutics Misses EPS, Beats Revenue for Q2 2024 - MSN at news.google.com
23rd of December 2024
Disposition of 3792 shares by Vivo Capital Viii, Llc of Bolt Biotherapeutics at 0.92 subje... at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bolt Biotherapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bolt Biotherapeutics' short interest history, or implied volatility extrapolated from Bolt Biotherapeutics options trading.
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.